Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies

Clinical trial NCT03043547 · COMPLETED

Trial details

NCT number: NCT03043547
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma Non-resectable Cholangiocarcinoma Metastatic Cholangiocarcinoma of the Gallbladder Cholangiocarcinoma Advanced

Start date: 2017-10-24
Primary completion: 2021-12-08
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.